case transmission (dependence of cases). On the other hand, the most plausible explanation for the totality of the EUR-OCLUS results is that small epidemics of (some unknown) infection(s) lead to increased risk of childhood leukaemia.
We apologise if we have given inadequate weight to the methods used by Hoffman and Straif to assess completeness and validity of case assessment in their study; we are pleased that they are able to emphasise this point for themselves. We are also pleased that they confirm that 'the observed incidence
Persistent polyclonal lymphocytosis (PPLB)
TO THE EDITOR Roy et al 1 recently identified a patient with a large cell lymphoma complicating persistent polyclonal lymphocytosis (PPBL). At diagnosis, the 38-year-old female presented an absolute lymphocytosis and the peripheral blood smears examination showed the presence of binucleated cells. The lymphocytosis was regarded as polyclonal based on immunologic and molecular studies. Nineteen years after the initial diagnosis of PPBL, the patient developed a large B cell lymphoma. Despite three cycles of CHOP regimen and autologous bone marrow transplantation, the patient rapidly died from progressive disease.
Roy et al claim that no consistent chromosomal abnormalities are present in PPBL patients. We initially reported a cytogenetic analysis in seven PPBL patients. The criteria we used for the diagnosis are similar to those of Roy: they include a persistent B cell lymphocytosis, negative for CD5 antigen and showing a normal kappa/lambda ratio on flow cytometry analysis, the presence of typical binucleated lymphocytes and a polyclonal increase in serum IgM immunoglobulin. We identified the presence of an extra chromosome 3 long arm i(3q) in six cases; furthermore, premature chromosome condensation was detected in all seven cases. 2 In a more recent study, we 3 and others 4 confirmed this chromosome abnormality. Isochromosome +i(3q) is very unusual in hematological malignancies. Karyotypic analysis has shown a high incidence of trisomy 3(q) in patients with marginal zone B cell lymphoma. 5 Gain of 3q was also observed in embryonal rhabdomyosarcomas, head and neck squamous cell carcinomas, primary small cell carcinomas and interestingly during the progression from severe dysplasia to invasive cervix carcinomas. 6 The impact of this chromosome abnormality is unknown: a genetic alteration present on the i(3q) can inhibit muscle differentiation and cause numerous cell cycle abnormalities. The microcell chromosome transfer of i(3q) into the myoblast cell line C2C12 can inhibit differentiation, cause abnormal cytokinesis, centrosome amplification, aneuploidy and abolish G1 arrest following DNA damage. 7 In order to demonstrate a direct relationship between PPBL and the malignant B large cell lymphoma, it could have been useful to perform an extensive cytogenetic analysis on peripheral lymphoid cells and lymphoid tumoral cells.
Whether patients with PPBL are at increased risk of hematologic malignancy remains unclear. In our experience concern- Inhibition of the apoptosis is one of the procedures leading to the accumulation of peripheral blood lymphoid cells in PPBL patients. In the report by Delage et al, bcl2/Ig gene was rearranged in six patients, with multiple rearrangements in five. Similar findings were observed in 5 additional patients. 8 Using a seminested polymerase chain reaction, a recent study showed six of nine healthy blood donors presented t(14;18) breakpoints: translocations were restricted to B cells, with an estimated frequency of 1 in 10 5 or less circulating B cells.
